In the article the data on clinical-microbiological researches in pregnant woman is shown. The high frequency of bacterial vaginosis and urogenital candidiasis in all trimesters of pregnancy is shown. For bacterial vaginosis treatment (13) and urogenital candidosis (12) we used local application of the combined terginan preparation in pregnant women in III trimester. The efficiency of its application estimated in 2 weeks after termination of treatment. Is ascertained, that at 84 % of the pregnant women with bacterial vaginosis and urogenital candidiasis positive result is observed. It is recommended to apply terginan for bacterial vaginosis urogenital candidiasis treatment in pregnant women.

Clinical effectiveness gyno-pevaryl (GP) is investigated at treatment acute (30 women) and chronic (38 patients) candidosis vulvovaginitis in the period of pregnancy. In an end of course of treatment GP clinical and laboratory the confirmed recovery is marked in the first group at 80.0 % patients, in the second and the third - at 76.3 % patients. Gynopevaryl is an effective preparation for local treatment acute and chronic candidosis vulvovaginitis.

Betadine can be recommended for the treatment of vaginitis in pregnant women in order to improve the microbiocenosis before childbirth and for the prevention of postpartum infectious complications.

The pregnancies and labors in two groups of women is analysed, who have endured acute salpingoophoritits. The first group of women has received treatment only in the hospital, second group except stationary treatment were conducted with rehabilitation measure in OB clinic and in a sanatorium. At the second group of women the complication of pregnancies like miscarriages and abortions has considerably decreased. Less often they developed hypoxia and needed CS.